These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. Law M; Oh S; Babb JS; Wang E; Inglese M; Zagzag D; Knopp EA; Johnson G Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838 [TBL] [Abstract][Full Text] [Related]
5. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107 [TBL] [Abstract][Full Text] [Related]
6. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Emblem KE; Nedregaard B; Nome T; Due-Tonnessen P; Hald JK; Scheie D; Borota OC; Cvancarova M; Bjornerud A Radiology; 2008 Jun; 247(3):808-17. PubMed ID: 18487536 [TBL] [Abstract][Full Text] [Related]
7. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas. Ellingson BM; Zaw T; Cloughesy TF; Naeini KM; Lalezari S; Mong S; Lai A; Nghiemphu PL; Pope WB J Magn Reson Imaging; 2012 Jun; 35(6):1472-7. PubMed ID: 22281731 [TBL] [Abstract][Full Text] [Related]
8. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. Sugahara T; Korogi Y; Kochi M; Ikushima I; Hirai T; Okuda T; Shigematsu Y; Liang L; Ge Y; Ushio Y; Takahashi M AJR Am J Roentgenol; 1998 Dec; 171(6):1479-86. PubMed ID: 9843274 [TBL] [Abstract][Full Text] [Related]
9. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Shin JH; Lee HK; Kwun BD; Kim JS; Kang W; Choi CG; Suh DC AJR Am J Roentgenol; 2002 Sep; 179(3):783-9. PubMed ID: 12185064 [TBL] [Abstract][Full Text] [Related]
10. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790 [TBL] [Abstract][Full Text] [Related]
11. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Warmuth C; Gunther M; Zimmer C Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of methods for determining vascular permeability and blood volume in human gliomas. Harrer JU; Parker GJ; Haroon HA; Buckley DL; Embelton K; Roberts C; Balériaux D; Jackson A J Magn Reson Imaging; 2004 Nov; 20(5):748-57. PubMed ID: 15503330 [TBL] [Abstract][Full Text] [Related]
13. High- and low-grade glioma differentiation: the role of percentage signal recovery evaluation in MR dynamic susceptibility contrast imaging. Aprile I; Giovannelli G; Fiaschini P; Muti M; Kouleridou A; Caputo N Radiol Med; 2015 Oct; 120(10):967-74. PubMed ID: 25762408 [TBL] [Abstract][Full Text] [Related]
14. Conventional MR imaging with simultaneous measurements of cerebral blood volume and vascular permeability in ganglioglioma. Law M; Meltzer DE; Wetzel SG; Yang S; Knopp EA; Golfinos J; Johnson G Magn Reson Imaging; 2004 Jun; 22(5):599-606. PubMed ID: 15172052 [TBL] [Abstract][Full Text] [Related]
15. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. Siegal T; Rubinstein R; Tzuk-Shina T; Gomori JM J Neurosurg; 1997 Jan; 86(1):22-7. PubMed ID: 8988077 [TBL] [Abstract][Full Text] [Related]
16. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889 [TBL] [Abstract][Full Text] [Related]
17. Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas. Di Costanzo A; Pollice S; Trojsi F; Giannatempo GM; Popolizio T; Canalis L; Armillotta M; Maggialetti A; Carriero A; Tedeschi G; Scarabino T Radiol Med; 2008 Feb; 113(1):134-43. PubMed ID: 18338133 [TBL] [Abstract][Full Text] [Related]
19. Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Bagley LJ; Grossman RI; Judy KD; Curtis M; Loevner LA; Polansky M; Detre J Radiology; 1997 Feb; 202(2):511-6. PubMed ID: 9015082 [TBL] [Abstract][Full Text] [Related]
20. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. Young R; Babb J; Law M; Pollack E; Johnson G J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]